The Contrast Media/Contrast Agent Market size is projected to accrue voluminously by 2029 registering a phenomenal CAGR of 3.65% during the review period (2022 to 2029).
A new report from Exactitude Consultancy Research, titled Global Contrast Media/Contrast Agent Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Contrast Media/Contrast Agent market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global market.
With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the global market. We have also focused on SWOT, PESTLE, and Porter’s Five Forces analyses of the global Semiconductor Test Claw market.
Get Sample Pages PDF (Including Full TOC, Table & Figures)
Competitors in Contrast Media/Contrast Agent Market Report Are E Healthcare, Bracco Imaging SPA, Bayer AG, Guerbet, Nano Therapeutics Pvt. Ltd., Lantheus Medical Imaging, Inc., iMax, Trivitron Healthcare, Jodas Expoim, and Spago Nanomedical AB, and others.
Complete Growth Report Is Available (Including the Full TOC, Tables And Figures, Graphs As Well As Chart)
https://exactitudeconsultancy.com/post/contrast-media-contrast-agent-market-growth/
Key Segments
Contrast Media/Contrast Agent Market by Type, 2022-2029, (USD Million)
Barium-Based Contrast Media
Iodinated Contrast Media
Gadolinium-Based Contrast Media
Microbubble Contrast Media
Contrast Media/Contrast Agent Market by Route of Administration, 2022-2029, (USD Million)
Oral
Rectal
Intravenous
Ureteral
Contrast Media/Contrast Agent Market by Indication, 2022-2029, (USD Million)
Cardiovascular Disease
Oncology
Gastrointestinal Disorders
Neurological Disorders
Other Indications
Contrast Media/Contrast Agent Market by Modality, 2022-2029, (USD Million)
X-Ray/Ct
MRI
Ultrasound
Contrast Media/Contrast Agent Market by Application, 2022-2029, (USD Million)
Oncology
Cardiology
Neurology
Contrast Media/Contrast Agent Market by End User, 2022-2029, (USD Million)
Hospital
Clinic
Diagnostic Centre
Regional Dominance: (Future of Keyword Market)
The research report on the global keyword market discusses current market trends, development overviews, and different research methodology. It outlines important market-manipulating elements, such as manufacturing tactics, software architectures, and product portfolios. According to our analysts, even slight modifications to product characteristics can have a significant negative impact on the aforementioned criteria.
North America includes the United States, Canada, and Mexico
Europe includes Germany, France, UK, Italy, Spain
South America includes Colombia, Argentina, Nigeria, and Chile
The Asia Pacific includes Japan, China, Korea, India, Saudi Arabia, and Southeast Asia and Rest Of the World
There Are 6 Sections To Show The Global Keyword Market:
1. Introduction
• Research Scope
• Market Segmentation
• Research Methodology
• Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
• Contrast Media/Contrast Agent Market Drivers
• Contrast Media/Contrast Agent Market Restraints
• Market Opportunities
4. Key Insights
• Key Emerging Trends for Major Countries
• Latest Technological Advancement
• Insight on Regulatory Landscape
• Industry SWOT Analysis
• Porters Five Forces Analysis
5. Qualitative Analysis Impact of COVID-19
• Impact of COVID-19 on the Contrast Media/Contrast Agent Market
• Steps Taken by the Government to Overcome the Impact
• Key Developments in the Industry in Response to COVID-19
• Potential Opportunities and Challenges due to COVID-19 Outbreak
6. Global Contrast Media/Contrast Agent Market (USD Billion) Analysis, Insights, and Forecast, 2022-2029.
Complete growth Report of Keyword Market
https://exactitudeconsultancy.com/reports/7789/contrast-media-contrast-agent-market/
About Us
Exactitude Consultancy is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.
Connect Us:
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
According to research report the Contrast Media Contrast Agent Market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911Growth in the market can primarily be attributed to the rising volume of CT and MRI examinations globally, and the rapidly growing cancer and CVD population across the globe, increasing number of approvals of contrast agents.
Rising research activities on contrast agents & their applications are the key areas of opportunity in this marketGE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France) are some of the leading players in the Contrast Media Contrast Agent Market.
Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B.
Chemicals (India), Sanochemia (Austria), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India).Recent Developments:> In 2017, GE Healthcare (US) launched a new Macrocyclic MRI contrast agent, Clariscan, in Europe.> In 2019, Bayer AG (Germany) received FDA approval for Gadavist as the first contrast agent for cardiac MRI.> In 2019, Guerbet Group partnered with IBM Watson Health for AI in medical imaging to support liver cancer diagnostics, utilizing CT and MRI imaging.Based on type, the contrast media market is segmented into iodinated contrast media, gadolinium-based contrast media, barium-based contrast media, and microbubble contrast media.
In 2019, the iodinated contrast media segment is estimated to account for the largest share of the contrast media industry.
The large share of this segment can be attributed due to its high usage in CT examinations coupled with the fact that it can be used in almost all body parts.Based on modality, the contrast agent market is segmented into X-ray/CT, MRI, and ultrasound procedures.